Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis

This review of 18 RCTs (n=3,042) found that inhaled anti-pseudomonal antibiotic treatment probably improves lung function and reduces exacerbation rate, but pooled estimates of the level of benefit were very limited. The best evidence is for inhaled tobramycin

Source: Current Awareness Service for Health (CASH) - June 8, 2018 Category: Consumer Health News Source Type: news